These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31701457)

  • 1. Assessment of Urinary MicroRNAs by Quantitative Polymerase Chain Reaction in Diabetic Nephropathy Patients.
    Newbury LJ; Wonnacott A; Simpson K; Bowen T; Fraser D
    Methods Mol Biol; 2020; 2067():277-285. PubMed ID: 31701457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Exosomal microRNA-451-5p Is a Potential Early Biomarker of Diabetic Nephropathy in Rats.
    Mohan A; Singh RS; Kumari M; Garg D; Upadhyay A; Ecelbarger CM; Tripathy S; Tiwari S
    PLoS One; 2016; 11(4):e0154055. PubMed ID: 27101382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes.
    El-Samahy MH; Adly AA; Elhenawy YI; Ismail EA; Pessar SA; Mowafy ME; Saad MS; Mohammed HH
    J Diabetes Complications; 2018 Feb; 32(2):185-192. PubMed ID: 29175120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary biomarkers in diabetic nephropathy.
    Soltani-Fard E; Taghvimi S; Karimi F; Vahedi F; Khatami SH; Behrooj H; Deylami Hayati M; Movahedpour A; Ghasemi H
    Clin Chim Acta; 2024 Jul; 561():119762. PubMed ID: 38844018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of certain urinary microRNAs as promising biomarkers in diabetic nephropathy patients using gold nanoparticles.
    Nossier AI; Shehata NI; Morsy SM; Saeed DF; Elsayed NM; Ismail MF; Eissa S
    Anal Biochem; 2020 Nov; 609():113967. PubMed ID: 32950495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of RNA isolation methods for microRNA quantification in a range of clinical biofluids.
    Roest HP; IJzermans JNM; van der Laan LJW
    BMC Biotechnol; 2021 Aug; 21(1):48. PubMed ID: 34362351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis.
    Park S; Moon S; Lee K; Park IB; Lee DH; Nam S
    Cell Physiol Biochem; 2018; 46(4):1331-1340. PubMed ID: 29689545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.
    Yang Y; Xiao L; Li J; Kanwar YS; Liu F; Sun L
    Med Hypotheses; 2013 Aug; 81(2):274-8. PubMed ID: 23683774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary microRNA profiling in the nephropathy of type 1 diabetes.
    Argyropoulos C; Wang K; McClarty S; Huang D; Bernardo J; Ellis D; Orchard T; Galas D; Johnson J
    PLoS One; 2013; 8(1):e54662. PubMed ID: 23358711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Droplet Digital PCR for Absolute Quantification of Extracellular MicroRNAs in Plasma and Serum: Quantification of the Cancer Biomarker hsa-miR-141.
    Giraldez MD; Chevillet JR; Tewari M
    Methods Mol Biol; 2018; 1768():459-474. PubMed ID: 29717459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease.
    Beltrami C; Simpson K; Jesky M; Wonnacott A; Carrington C; Holmans P; Newbury L; Jenkins R; Ashdown T; Dayan C; Satchell S; Corish P; Cockwell P; Fraser D; Bowen T
    Am J Pathol; 2018 Sep; 188(9):1982-1992. PubMed ID: 29981742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy.
    Cardenas-Gonzalez M; Srivastava A; Pavkovic M; Bijol V; Rennke HG; Stillman IE; Zhang X; Parikh S; Rovin BH; Afkarian M; de Boer IH; Himmelfarb J; Waikar SS; Vaidya VS
    Clin Chem; 2017 Sep; 63(9):1515-1526. PubMed ID: 28667184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease.
    Eissa S; Matboli M; Aboushahba R; Bekhet MM; Soliman Y
    J Diabetes Complications; 2016; 30(8):1585-1592. PubMed ID: 27475263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
    Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary MicroRNAs as Emerging Class of Noninvasive Biomarkers.
    Juracek J; Slaby O
    Methods Mol Biol; 2020; 2115():221-247. PubMed ID: 32006404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased Urine miR-199-3p may be a Potential Biomarker for Diabetic Nephropathy via Targeting Zinc Finger E-box-Binding Protein 1.
    Meng L; Li G; Liu X; Jiang J; Zhu M; Sun Y
    Clin Lab; 2018 Jul; 64(7):1177-1182. PubMed ID: 30146830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary mRNA levels of ELR-negative CXC chemokine ligand and extracellular matrix in diabetic nephropathy.
    Wang G; Lai FM; Chow KM; Kwan BC; Pang WF; Luk CC; Leung CB; Li PK; Szeto CC
    Diabetes Metab Res Rev; 2015 Oct; 31(7):699-706. PubMed ID: 25865428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of urinary microRNA profiling detection in intrahepatic cholestasis of pregnancy and its potential as a non-invasive biomarker.
    Ma L; Zhang XQ; Zhou DX; Cui Y; Deng LL; Yang T; Shao Y; Ding M
    Sci Rep; 2016 Aug; 6():31535. PubMed ID: 27534581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study.
    Kopkova A; Sana J; Fadrus P; Machackova T; Vecera M; Vybihal V; Juracek J; Vychytilova-Faltejskova P; Smrcka M; Slaby O
    PLoS One; 2018; 13(12):e0208580. PubMed ID: 30532175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.